Overview
Access
/time_series
data via our API — starting from the
Basic plan and above.
Description
Britannia Life Sciences Inc. is a global product development platform specializing in laboratory support services for the cosmetics, consumer goods, wellness, food, nutraceutical, and cannabis industries. The company provides an integrated suite of services across the product development lifecycle, from concept to consumer, including testing, safety assessment, compliance, and product formulation. Its ISO 17025 accredited laboratory, previously focused on UK and European markets, supports businesses with advanced analytical services, while subsidiaries like Britannia Labs cater to the global cannabis sector and Proof Wellness offers a validated online marketplace for high-quality CBD products in the UK. Notable strategic moves include the divestiture of its UK lab and testing business for up to CAD$43.6 million, the appointment of a CEO for its Global Consumer Products Division, and partnerships like the Green Bridge Gateway to facilitate UK CBD market access. Britannia Life Sciences Inc. leverages a global supply chain to deliver uncompromised quality and value to customers worldwide.
About
CEO
Mr. Peter James Shippen C.A.I.A., C.P.A., CFA
Employees
—
Address
120 Adelaide Street West
Suite 2400
Toronto, M5H 1T1, ON
Canada
Suite 2400
Toronto, M5H 1T1, ON
Canada
Phone
416 433 9259
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
PINX